Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma.
Brendan D CurtiMarka CrittendenSteven K SeungChristopher B FountainRoxanne PayneShuChing ChangJessica FleserKimberly PhillipsIan MalkasianLyn B DobrunickWalter J UrbaPublished in: Journal for immunotherapy of cancer (2021)
NCT01416831.